Published in PLoS One on September 09, 2016
Antinuclear antibody testing - misunderstood or misbegotten? Nat Rev Rheumatol (2017) 0.76
Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol (1989) 8.02
International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis (2013) 3.99
The nucleosome: from genomic organization to genomic regulation. Cell (2004) 3.83
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. Arthritis Rheum (2011) 3.81
A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus. Arthritis Rheum (2009) 3.34
Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum (1997) 3.29
Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum (2002) 2.99
Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med (2008) 2.97
The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol (2010) 2.93
The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol (2006) 2.90
ANA screening: an old test with new recommendations. Ann Rheum Dis (2010) 2.21
Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Arch Pathol Lab Med (2000) 2.07
Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol (2011) 2.05
Remnants of secondarily necrotic cells fuel inflammation in systemic lupus erythematosus. Arthritis Rheum (2009) 2.04
A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity. Arthritis Rheum (1999) 1.85
Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response. Ann Rheum Dis (2012) 1.67
Abnormal antinuclear antibody titers are less common than generally assumed in established cases of systemic lupus erythematosus. J Rheumatol (2008) 1.66
An enzyme-linked immunosorbent assay for antibodies to native and denatured DNA. J Immunol Methods (1979) 1.53
Autoantigens are translocated into small apoptotic bodies during early stages of apoptosis. Cell Death Differ (2007) 1.50
Nucleosome disassembly intermediates characterized by single-molecule FRET. Proc Natl Acad Sci U S A (2009) 1.44
Preparation of nucleosomes and chromatin. Methods Enzymol (1989) 1.41
Disturbances of apoptotic cell clearance in systemic lupus erythematosus. Arthritis Res Ther (2011) 1.39
Microplate ELISA for detection of antibodies to DNA in patients with systemic lupus erythematosus: specificity and correlation with Farr radioimmunoassay. J Clin Lab Anal (1989) 1.39
An improved ELISA for anti-native DNA by elimination of interference by anti-histone antibodies. J Immunol Methods (1983) 1.36
DNA "melting" proteins. I. Effects of bovine pancreatic ribonuclease binding on the conformation and stability of DNA. J Biol Chem (1976) 1.27
Evaluation of the BioPlex 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies. Ann N Y Acad Sci (2005) 1.22
Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus. J Autoimmun (2011) 1.18
Release of DNA from dead and dying lymphocyte and monocyte cell lines in vitro. Scand J Immunol (2004) 1.14
Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period. Mod Rheumatol (2008) 1.13
Apoptosis-induced histone H3 methylation is targeted by autoantibodies in systemic lupus erythematosus. Ann Rheum Dis (2010) 1.10
Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis. Autoimmun Rev (2012) 1.07
Enzyme-linked immunosorbent assay screening then indirect immunofluorescence confirmation of antinuclear antibodies: a statistical analysis. Am J Clin Pathol (2011) 1.05
Autoantibody detection using multiplex technologies. Lupus (2006) 1.02
Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity. Lupus (2011) 1.00
Enzyme-linked immunosorbent assay for antibodies to native DNA in sera of patients with SLE. J Immunol Methods (1982) 0.99
Nucleic acid-binding polymers as anti-inflammatory agents. Proc Natl Acad Sci U S A (2011) 0.98
Long-term follow-up of autoantibody profiles in black female lupus patients and clinical comparison with Caucasian and Asian patients. Br J Rheumatol (1997) 0.97
Effect of corticosteroid use by dose on the risk of developing organ damage over time in systemic lupus erythematosus-the Hopkins Lupus Cohort. Lupus Sci Med (2015) 0.95
Mimotopes for lupus-derived anti-DNA and nucleosome-specific autoantibodies selected from random peptide phage display libraries: facts and follies. J Immunol Methods (2004) 0.94
Ro/SS-A and La/SS-B antibody level variation in patients with Sjögren's syndrome and systemic lupus erythematosus. J Autoimmun (1998) 0.93
The variation in anti-ENA characteristics between different ethnic populations with systemic lupus erythematosus over a 10-year period. Lupus (2000) 0.93
A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers' laboratories. J Rheumatol (2003) 0.93
Circulating Apoptotic Microparticles in Systemic Lupus Erythematosus Patients Drive the Activation of Dendritic Cell Subsets and Prime Neutrophils for NETosis. Arthritis Rheumatol (2016) 0.92
The blood nucleome in the pathogenesis of SLE. Autoimmun Rev (2010) 0.91
A simple, rapid ELISA method for the detection of DNA antibodies. J Clin Pathol (1982) 0.90
Autoantibodies in SLE but not in scleroderma react with protein-stripped nucleosomes. J Autoimmun (2004) 0.89
BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus. Autoimmunity (2009) 0.89
Comparison of antinuclear antibody testing methods: immunofluorescence assay versus enzyme immunoassay. Clin Diagn Lab Immunol (1997) 0.89
Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus. J Rheumatol (2005) 0.88
2013 update: Hopkins lupus cohort. Curr Rheumatol Rep (2013) 0.88
Mitochondrial Extrusion through the cytoplasmic vacuoles during cell death. J Biol Chem (2008) 0.88
Screening for IgG antinuclear autoantibodies by HEp-2 indirect fluorescent antibody assays and the need for standardization. Am J Clin Pathol (2012) 0.87
The interaction of DNA with pancreatic ribonuclease A. Biochim Biophys Acta (1969) 0.86
Lupus-derived monoclonal autoantibodies against apoptotic chromatin recognize acetylated conformational epitopes. Mol Immunol (2010) 0.85
Detection of antinuclear antibodies by use of an enzyme immunoassay with nuclear HEp-2 cell extract and recombinant antigens: comparison with immunofluorescence assay in 307 patients. Clin Chem (2001) 0.83
Structural dynamics of nucleosomes at single-molecule resolution. Trends Biochem Sci (2012) 0.83
Screening of antinuclear antibodies: comparison between enzyme immunoassay based on nuclear homogenates, purified or recombinant antigens and immunofluorescence assay. Clin Chem Lab Med (2004) 0.83
Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus. Arthritis Res Ther (2015) 0.81
The inhibition of anti-DNA binding to DNA by nucleic acid binding polymers. PLoS One (2012) 0.81
Presence of RNase A causes aberrant DNA band shifts. Biotechniques (1997) 0.81
Autoantibody detection with indirect immunofluorescence on HEp-2 cells: starting serum dilutions for systemic rheumatic diseases. Immunol Lett (2011) 0.80
Measurement of antinuclear antibodies by multiplex immunoassay: a prospective, multicenter clinical evaluation. J Rheumatol (2007) 0.80
The uses and misuses of multiplex autoantibody assays in systemic autoimmune rheumatic diseases. Front Immunol (2015) 0.80
Nucleic acid scavenging polymers inhibit extracellular DNA-mediated innate immune activation without inhibiting anti-viral responses. PLoS One (2013) 0.79
Nucleic acid-binding polymers as anti-inflammatory agents: reducing the danger of nuclear attack. Expert Rev Clin Immunol (2012) 0.78
Antinuclear antibodies defining autoimmunity pathways. Arthritis Res Ther (2014) 0.77
DNA interaction with RNase A alters protein conformation. DNA Cell Biol (2007) 0.76
Immobilization of nucleic acid binding polymers as anti-inflammatory agent in autoimmunity. J Control Release (2015) 0.76